Navigation Links
Cardium to Present at Sachs Associates 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences
Date:5/17/2012

SAN DIEGO, May 17, 2012 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today announced that Christopher J. Reinhard, Chairman & CEO will present a corporate overview and participate in a Regenerative Medicine Panel being held at the Sachs 2012 Science, Partner, and Investment Forum: Gateway for the Global Life Sciences in West Palm Beach, FL May 21 – 22, 2012.  The Regenerative Medicine Panel, chaired by Bernard Siegel, Executive Director, Genetics Policy Institute and Jeffrey Cohen, Director, Ladenburg Thalmann & Co, Inc., will take place on May 22 at 9:15 a.m. ET and Cardium's investor presentation is scheduled for 10:40 a.m. ET on the same day in Ballroom B.

(Logo: http://photos.prnewswire.com/prnh/20051018/CARDIUMLOGO)

An updated investor presentation is now available on Cardium's website at http://phx.corporate-ir.net/phoenix.zhtml?c=77949&p=irol-presentations.

About Cardium

Cardium is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs that have definable pathways to commercialization, partnering and other economic monetizations.  Cardium's current medical opportunities portfolio, which is focused on health sciences and regenerative medicine, includes the Tissue Repair Company, Cardium Biologics, and the Company's in-house MedPodium Health Sciences healthy lifestyle product platform.  The Company's lead commercial product Excellagen™ topical gel for wound care management recently received FDA clearance for marketing and sale in the United States.  Cardium's lead clinical development product candidate Generx® is a DNA-based
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Cardium Announces Agreement With UK-Based Angel Biomedical For Excellagen Supply And Planned European Market Expansion
2. Cardium Exhibiting Its New FDA-Cleared Excellagen® At The 2012 Spring Symposium Of Advanced Wound Care
3. Smith Medical Partners Announces Logistics Agreement for Cardiums National Distribution of Excellagen™
4. Cardium Announces Closing of $5.0 Million Equity Financing
5. Cardium Regains Listing Compliance With NYSE Amex
6. Cardium Announces First International Marketing and Distribution Agreement for Commercialization of Excellagen™ in South Korea
7. Cardium Reports on Renewed Compliance With NYSE Amex Exchange Listing Guidelines
8. Cardium and SourceOne Global Partners Enter Into Cross-Strategic Equity Investment with Plans to Jointly Develop Nutritional Supplements and Medical Foods
9. Cardium to Present at the Rodman & Renshaw Annual Healthcare Investment Conference
10. Cardium Provides Update on Exchange Listing and Related Business Matters
11. Cardium to Present at Southern California Investor Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... 2, 2015  ArmaGen, Inc., a privately held ... treat severe neurological disorders, announced today that the ... Phase 1/2a clinical trial of AGT-181 in patients ... AGT-181 is an investigational enzyme replacement ... The most severe form of MPS I, Hurler ...
(Date:9/2/2015)... , Sept. 2, 2015 Unilife Corporation ("Unilife" ... UNS), a developer, manufacturer and supplier of injectable drug ... initiated expressions of interest, the Company,s Board of Directors ... a review of strategic alternatives to maximize shareholder value. ... and evaluated during the review process may include a ...
(Date:9/2/2015)... , September 2, 2015 According ... by Product (Digital & Computed Radiography, Ultrasound, Computed & ... PACS) by Application (Oncology, Cardiology, Neurology) - Global Forecast ... to reach USD 2.8 Billion by 2020 growing at ... Br owse 240 Tables and 44 ...
Breaking Medicine Technology:ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 2ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 3ArmaGen Announces First Patient Dosed in Phase 1/2a Clinical Trial of AGT-181 for the Treatment of Hurler Syndrome 4Unilife Announces Review of Strategic Alternatives 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 2Veterinary Imaging Market Worth USD 2.8 Billion by 2020 3Veterinary Imaging Market Worth USD 2.8 Billion by 2020 4Veterinary Imaging Market Worth USD 2.8 Billion by 2020 5
(Date:9/3/2015)... ... September 03, 2015 , ... ... Bob Anders and Kelley Chapman will be joining the company’s executive leadership team ... Anders has over 30 years’ experience in healthcare product and project management. He ...
(Date:9/3/2015)... ... 03, 2015 , ... The partnership will leverage Fidson’s strong ... services to promote LodonalTM in Nigeria. The distribution will become effective, upon completion ... of the product. , Managing Director, Fidson Healthcare Plc, Dr Fidelis Ayebae, expressed ...
(Date:9/2/2015)... ... , ... The Aspen Clinic (TAC), located in Basalt, Colorado, today ... inspiring wellness in the Roaring Fork Valley and beyond. , Amanda Wagner, Executive Director ... to fitness - we are much more than a gym. Our fitness and ...
(Date:9/2/2015)... ... ... One can hardly argue against the fact that more and more people ... These devices are being used as GPS, to make purchases, and yes, even to ... positive singles can now join the prestigious social ranks of e-dating. , Recently, ...
(Date:9/2/2015)... Washington, DC (PRWEB) , ... September 03, 2015 ... ... stacks of nominations to determine who among America’s policymakers, public servants, activists, corporate ... on the nation’s health care. This year, that process led the magazine to ...
Breaking Medicine News(10 mins):Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 2Health News:Leading Post-Acute EMR Provider HealthWyse Names Bob Anders as VP Product and Kelley Chapman VP Engineering 3Health News:Fidson Partners US Firms on New Product Marketing 2Health News:Fidson Partners US Firms on New Product Marketing 3Health News:Fidson Partners US Firms on New Product Marketing 4Health News:TAC Introduces New Retreats for Fall Fitness 2Health News:Herpes-datingsites.com Recently Added Reviews of 5 STD Dating Apps for STD Positive Singles 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 2Health News:NLN CEO Dr. Beverly Malone Named One of 100 Most Influential in Health Care 3
... Report Injects a Dose of Reality into the Debate on the State ... ... The AIDS Vaccine Advocacy,Coalition (AVAC) today released a new report that ... 2008:,The Search Must Continue explores the issues that have been raised in ...
... 15 HealthSTAR Public Relations, LLC,(HSPR) announced today that ... President., Prior to joining HSPR, Soffer managed the ... She has 14,years of industry experience at agencies including ... the majority of her career. She began,her career at ...
... shown that an electric shock ranging from 120 to ... humans. , Following an electrical injury, some patients ... memory loss and symptoms of depression. , The ... by clinicians from the Universit de Montrals Faculty of ...
... live, LAVAL, QC, May 15 /PRNewswire-FirstCall/ - ... as Neurochem Inc.) announces today that on,Monday, May ... and Chief Executive Officer will present BELLUS Health,s ... Healthcare Conference to be,held at the Le Meridien ...
... and Control for Lead ... Removal, ... today announced the availability of the new LLD,EZ Lead Locking Device (LLD) ... EZ enables physicians to secure,the entire lead creating traction to enable the ...
... obese and lead unhealthy lifestyles are more likely to ... to a population-based study of more than 5,000 men ... UK-based urology journal BJU International. Researchers hope the results ... how they can be managed more effectively. , ...
Cached Medicine News:Health News:Immunizing Against Misinformation and Shortsightedness 2Health News:Immunizing Against Misinformation and Shortsightedness 3Health News:Immunizing Against Misinformation and Shortsightedness 4Health News:HealthSTAR Public Relations Hires Hayley Soffer, Executive Vice President 2Health News:Electric shocks can cause neurologic and neuropsychological symptoms 2Health News:BELLUS Health to present at the Rodman and Renshaw 5th Annual Global Healthcare Conference 2Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 2Health News:Spectranetics Introduces New Device for Removal of Non-Functional and Infected Cardiac Leads 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 2Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 3Health News:Obesity and unhealthy lifestyles linked to more complex urinary problems 4
... is an off-the-shelf wrist orthotic designed to limit the ... ranges-of-motion (20°,35° and 50°). , ,Indications: , ... tear-triangular fibrocartilage complex , Coles fracture - ... Partial tendon rupture , ORIF - ...
Contoured design provides secure support and immobilization of the wrist and distal forearm while preserving finger mobility...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
... Cronin, Inc. is a ... Footwear, Orthopedic Softgoods, and ... Our products are of ... available in the USA ...
Medicine Products: